Review
Cardiotoxicity of venetoclax and modern hematologic cancer therapy: the cardiologist’s role
Cardiovascular risk assessment and management during modern hematologic cancer therapy require collaboration among hematologists, oncologists, and cardiologists to balance treatment efficacy and cardiovascular safety.
#venetoclax clinicaloncology.com.ua